Form 4: Schrodinger Inc. Executive Margaret Dugan Reports Stock and Option Awards

Chief Medical Officer Margaret Dugan reports the grant of stock options and restricted stock units in Schrodinger, Inc.

Summary

• On March 3, 2025, Margaret Dugan, Chief Medical Officer of Schrodinger, Inc., was granted 12,500 restricted stock units (RSUs) and options to purchase 50,000 shares of common stock.
• The RSUs will vest in equal installments annually from March 4, 2026, to March 4, 2029, contingent upon continued service with the company.
• The stock options, priced at $21.24, vest 25% on March 3, 2026, and the remainder in equal monthly installments through March 3, 2029.
• Following these transactions, Dugan beneficially owns 25,969 shares of common stock, including 23,750 unvested RSUs, and options for 50,000 shares.

Sentiment

Score: 7

Explanation: The document reflects a neutral to slightly positive sentiment as it reports standard executive compensation practices, indicating confidence in the company's future.

Positives

• The grant of RSUs and stock options aligns the executive's interests with those of the shareholders.
• The vesting schedules incentivize continued service and performance.

Future Outlook

The document outlines the vesting schedule for the granted RSUs and stock options, indicating future equity compensation for the reporting person contingent on continued service.

Industry Context

Granting stock options and RSUs is a common practice in the biotech and pharmaceutical industries to attract, retain, and incentivize key executives. These grants align executive compensation with company performance and shareholder value.

Comparison to Industry Standards

• Stock option and RSU grants are standard compensation components for executives in publicly traded companies, particularly in the technology and biotechnology sectors.
• Companies like Moderna, BioNTech, and Regeneron also utilize similar equity-based compensation plans to incentivize their leadership teams.
• The vesting schedules described are typical, with vesting occurring over a multi-year period to encourage long-term commitment.

Stakeholder Impact

• Shareholders may view the equity grants as a positive sign, aligning management's interests with long-term company success.
• Employees may see the grants as a reflection of the company's commitment to its leadership team.

Key Dates